Evaluation of Cognitive Function in a Suicidal Crisis
NCT03519802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2025-12-23
Summary
The aftermath of suicide is devastating, being the cause of 800 000 deaths every year worldwide. In France, suicide still causes about 10 000 deaths per year and the number of suicide attempts (SA) is estimated between 170 000 and 200 000 per year (InVS).
It is often thought that a suicidal crisis is only related to depression, as it actually is a far more complex phenomenon. A suicidal crisis can occur on various grounds like psychiatric disorders but also contextual events or somatic diseases and it has been hypothesized that suicidal ideas or inclinations could have a common and independent cognitive origin
Conditions
- Suicide
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Vincent JARDON, MD · University Hospital, Lille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-20
- Primary Completion
- 2024-03-25
- Completion
- 2024-03-25
Countries
- France
Study Locations
More Related Trials
-
Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects
NCT00366483 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
NCT00188812 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
NCT01009255 ·Status: COMPLETED ·Phase: PHASE2
-
Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
NCT00675090 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Tolerability Study of GB301
NCT03865017 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
NCT00202540 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
NCT02249351 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
NCT01303744 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
NCT05262023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
NCT01492374 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
NCT01689233 ·Status: COMPLETED ·Phase: PHASE3
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
NCT04111211 ·Status: COMPLETED
-
Cytokines and Cognitive Decline in Alzheimer's Disease
NCT01351142 ·Status: COMPLETED ·Phase: NA
-
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
NCT05328115 ·Status: COMPLETED ·Phase: PHASE1
-
Cohort Study of Adult Patients With Down Syndrome at Risk of Developing Alzheimer's Disease (TriAL21)
NCT03901261 ·Status: UNKNOWN ·Phase: NA
-
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
NCT03698695 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Effect of Lecozotan SR on the QTc Interval
NCT00499642 ·Status: COMPLETED ·Phase: PHASE1
-
Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease
NCT00749216 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive Decline
NCT05199142 ·Status: TERMINATED ·Phase: PHASE1
-
Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients
NCT00479219 ·Status: COMPLETED ·Phase: PHASE1
-
MEMENTO-VAScular COmponents of Dementia
NCT02264899 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of Etanercept in Alzheimer's Disease
NCT01068353 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
NCT01230853 ·Status: COMPLETED ·Phase: PHASE1